Rep. Hudson Bills to Lower Drug Costs, Increase Oversight of China, Included in FDA Legislative Package
May 07, 2022
May 07, 2022
WASHINGTON, May 7 -- Rep. Richard Hudson, R-North Carolina, issued the following news release:
Two bills by U.S. Representative Richard Hudson (R-NC) have been included in the Food and Drug Administration (FDA) Act of 2022. Introduced by Energy and Commerce Health Subcommittee Republican Leader Brett Guthrie (R-KY) and Chairwoman Anna Eshoo (D-CA), the package reauthorizes the FDA User Fee Agreements and includes provisions led by Rep. Hudson and House Republicans to lower costs, sp . . .
Two bills by U.S. Representative Richard Hudson (R-NC) have been included in the Food and Drug Administration (FDA) Act of 2022. Introduced by Energy and Commerce Health Subcommittee Republican Leader Brett Guthrie (R-KY) and Chairwoman Anna Eshoo (D-CA), the package reauthorizes the FDA User Fee Agreements and includes provisions led by Rep. Hudson and House Republicans to lower costs, sp . . .